PDI showcases its latest innovations clinically proven to help healthcare facilities reduce preventable infections
PDI-International is excited to announce that we will be exhibiting at a number of leading shows over the next few months to showcase our latest products and technologies. Come and check out how you can get to the core of #infectionprevention and best protect patients and healthcare workers with our layered approach, designed to ensure that the right solutions and support are provided to achieve your infection control goals.
Where & when
- DECON UK 2023: Tuesday 18th April, Hilton Birmingham Metropole Hotel (Stand 13)
- Infection Prevention and Control Conference (IPC) 24th-25th April, The National Conference Centre, Birmingham (Stands 33 & 34)
- EBME-Expo, 28th-29th June, Coventry Building Society Arena, Coventry (Stand J12)
Come see our innovations up close and in action!
Expect to see our trusted range of Sani-Cloth® 2-in-1 cleaning and disinfection wipes, all made in Britain and designed to make cleaning extra easy and fast. This includes our Sani-Cloth® Chlor sporicidal disinfection wipes, ideal for disinfecting high-risk areas; our Super Sani-Cloth® – the #1 disinfecting wipe in healthcare in North America, compatible with more than 600 non-invasive medical devices and proven to kill all listed pathogens including norovirus in 1 minute; and our alcohol-free alternative Sani-Cloth® AF, ideal for routine cleaning and disinfecting.
We’ll also be demonstrating ground-breaking automated room and air disinfection systems, HyperDRYMist® and Novaerus. Lightweight and highly portable, HyperDRYMist® is perfect for small areas & ambulances, where alternative systems have difficulty in accessing due to their size. Its ability to disperse the low-toxic patented disinfectant solution into an ultrafine dry mist thanks to its innovative technology, makes it the ideal choice for any facility looking for exceptional efficacy, speed, compatibility, increased safety with low environmental impact.
WellAir’s advanced Novaerus air disinfection and cleaning solution contains patented NanoStrike™ nanotechnology designed to inactivate all airborne microorganisms on contact. The technology is tested and proven safe and effective in more than 30 independent laboratory studies and is ideal for rapid remediation in large to medium spaces where exposure to airborne pathogens is elevated.
In addition, look out for our newly launched Prevantics® premoistened swabstick containing 2% (w/w) Chlorhexidine gluconate (CHG) and 70% (v/v) Isopropyl alcohol (IPA) with a unique 2-sided applicator to ensure thorough skin disinfection in harder-to-reach places.
And not forgetting our new and improved Hygea hand hygiene cleansing and disinfection wipes, which are effective against viruses and bacteria; ideal to use for patients with limited mobility and healthcare workers when there is no reduced access to a sink.
…. And plenty more!
Our solutions have been developed and are clinically proven to help you build a solid strategy to tackle the most challenging areas when it comes to preventing the transmission of HAIs.
The burden of HAIs is a major concern across the world with an estimated 8.8 million patients affected across Europe in both acute and long-term care facilities with more than half being preventable1. Not only do HCAI result in poor outcomes for patients in terms of morbidity and mortality and but also has a huge cost to healthcare providers. Modelled annual costs to the NHS are in the region of £2.7 billlion2 and an estimated extended length of hospital stay of up to 25 days3 – what else could that money be usefully spent on and how else could the hospital beds be better utilised?
Commercial Director, Mike-Sullivan, said: “At PDI, we recognise that hospitals need a multipronged approach to ensure the highest level of cleanliness and infection prevention because no single approach can completely eliminate the environment of microorganisms. That’s why we provide market-leading products along with a consultative approach to help hospitals keep cross-contamination to an absolute minimum, while lowering costs.”
Book a meeting with our team!
If you’re attending DECON UK 2023, the Infection Prevention and Control Conference (IPC), or EBME Expo in June and would like to learn more about how we can support you in taking the best approach to infection control and prevention, please book a meeting with our team. Get in touch at: contact@pdi-emea.com.
We hope to see you there!
PDI International has been accredited as a member of Made-in-Britain and are proud to have joined the community of more than 1,200 British manufacturers. The mark reinforces our message to our customers that we pride ourselves on developing and manufacturing products synonymous with quality, rigorous regulations and standards, uninterrupted supply, and reduced CO2 footprint.
For more information about our range of premium infection control solutions, visit:
PDI International – Home – PDI International (pdi-intl.com)
References:
- Suetens et al. (2018) Prevalence of healthcare associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017 Euro Surveill.2018;23(46):pii=1800516. https://doi.org/10.2807/15607917.ES.2018.23.46.1800516
- Guest et al. (2019) Modelling the costs and consequences of reducing healthcare-associated infections by improving hand hygiene in an average hospital in England. BMJ Open 2019;9:e029971. doi:10.1136/bmjopen-2019-029971
- Stewart et al. (2021) Impact of healthcare-associated infection on length of stay Journal of Hospital Infection 114 (2021) 23-31